ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994

DRCCA Board Okays Cooperative Group Contract Extension, Nutrition Research Training Grants

February 6, 1981

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Eleven Chemicals Rated for Tests

September 1, 1978